Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.SE |
First Approval Date30 Dec 1997 |
100 Clinical Results associated with Scandinavian Regulatory Services AB
0 Patents (Medical) associated with Scandinavian Regulatory Services AB
100 Deals associated with Scandinavian Regulatory Services AB
100 Translational Medicine associated with Scandinavian Regulatory Services AB